REBECCA MEINERT: Open Payments
NPI 1417571399 · KANSAS CITY, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$327 in 19 payments from 5 companies in 2025. Trend: 2023 $207 · 2024 $300 · 2025 $327
Food & beverage: $327
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 15 | $213 |
| Smith+Nephew, Inc. | 1 | $46 |
| GlaxoSmithKline, LLC. | 1 | $29 |
| Regeneron Healthcare Solutions, Inc. | 1 | $24 |
| ABBVIE INC. | 1 | $15 |
Products named: DUPIXENT, HALO, NUCALA, UBRELVY.
Industry payments across KS — which companies pay providers there.
